Ascendis Pharma (ASND)
(Real Time Quote from BATS)
$140.94 USD
+3.90 (2.85%)
Updated Jul 16, 2024 01:20 PM ET
4-Sell of 5 4
F Value C Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Ascendis Pharma A/S [ASND/]
Reports for Purchase
Showing records 301 - 303 ( 303 total )
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
October and Full Year 2016 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
R-D Day Showcases a Deepening Pipeline; Reiterate OUTPERFORM and $34 Price Target
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
TransCon Technology Creates Best-In-Class SR-Prodrugs With Strong Intellectual Property; Initiating Coverage with an OUTPERFORM and $34 Price Target.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L